Australien - engelska - Department of Health (Therapeutic Goods Administration)

bridgewest perth pharma pty ltd - tranexamic acid, quantity: 1000 mg - injection, solution - excipient ingredients: water for injections - intravenous administration,adults,for the reduction of peri- and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery or total knee arthroplasty or total hip arthroplasty.,paediatrics,for the reduction of peri- and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery.

Saudiarabien - engelska - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

octapharma - tranexamic acid - solution for injection - 100 mg/ml

Australien - engelska - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - tranexamic acid -

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - tranexamic acid 500mg - tablet - 500 mg - active: tranexamic acid 500mg excipient: colloidal silicon dioxide hyprolose macrogol 8000 magnesium stearate   methacrylic acid copolymer microcrystalline cellulose povidone purified talc   titanium dioxide vanillin - haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis. local fibrinolysis may occur in the following conditions: · prostatectomy and bladder surgery · menorrhagia · epistaxis · conisation of the cervix · management of dental extraction in patients with coagulopathies · ulcerative colitis · haematuria · gastrointestinal haemorrhage. general fibrinolysis as in prostatic and pancreatic cancer; after thoracic and other major surgery: · in obstetrical complications such as abruptio placentae and post-partum haemorrhage · in leukaemia and liver diseases and in connection with thrombolytic therapy with streptokinase.

Kanada - engelska - Health Canada

sterimax inc - tranexamic acid - solution - 100mg - tranexamic acid 100mg - hemostatics

Australien - engelska - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - tranexamic acid -

Malta - engelska - Medicines Authority

central procurement & supplies unit - tranexamic acid - solution for injection - tranexamic acid 100 milligram(s)/millilitre - antihemorrhagics

Australien - engelska - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - tranexamic acid -

Australien - engelska - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - tranexamic acid -

Australien - engelska - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - tranexamic acid, quantity: 500 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; purified talc; magnesium stearate; colloidal anhydrous silica; povidone; hyprolose; titanium dioxide; macrogol 8000; vanillin; basic butylated methacrylate copolymer - hereditary angioneurotic oedema. short term use in the treatment of hyphaema and in patients with established coagulopathies who are undergoing minor surgery. menorrhagia.